Literature DB >> 28123583

Association of leptin, visfatin, apelin, resistin and adiponectin with clear cell renal cell carcinoma.

Hai-Ping Zhang1, Jian Zou2, Zhuo-Qun Xu3, Jun Ruan3, Shu-Dong Yang4, Ying Yin2, Hui-Jun Mu2.   

Abstract

Although an association between obesity and the occurrence of renal cell carcinoma (RCC) has been identified, the mechanism by which obesity functions to increase this risk of cancer remains unclear. Leptin, visfatin, apelin, resistin and adiponectin are peptide hormones secreted by adipocytes; it is considered that these may affect RCC development by exerting effects on proliferation, cell growth and inflammation. The aim of the present study was to investigate the association between the aforementioned adipokine genes and clear cell RCC (CC-RCC). The GSE6344 dataset was downloaded from the Gene Expression Omnibus database, and the relative expression levels of the adipokine genes were analyzed. To verify the results of the mRNA microarray, 77 paired samples of CC-RCC and corresponding adjacent normal tissue were allocated into two groups. The extraction of total RNA was conducted, and the mRNA expression of adipokine genes was analyzed using reverse transcription-quantitative polymerase chain reaction (RT-qPCR). The data from the GSE6344 dataset indicated that the expression of visfatin and apelin was upregulated (P<0.0001 and P<0.01, respectively), and adiponectin was downregulated (P<0.001) in the CC-RCC tissues compared with the adjacent normal tissues. The data from RT-qPCR demonstrated that visfatin and resistin gene expression was increased (P<0.01 and P<0.05, respectively) in the CC-RCC tissues. Furthermore, the mRNA expression level of leptin and adiponectin in the adjacent normal tissue was higher than those in the cancer tissue (P<0.01). The current study verifies that visfatin and adiponectin are associated with an increased risk of CC-RCC, which presents further insights into the molecular mechanisms of CC-RCC tumorigenesis.

Entities:  

Keywords:  adiponectin; apelin; leptin; renal cell carcinoma; resistin; visfatin

Year:  2016        PMID: 28123583      PMCID: PMC5244984          DOI: 10.3892/ol.2016.5408

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  50 in total

Review 1.  Endocrinology of adipose tissue - an update.

Authors:  P Fischer-Posovszky; M Wabitsch; Z Hochberg
Journal:  Horm Metab Res       Date:  2007-05       Impact factor: 2.936

Review 2.  Functional and structural features of adipokine family.

Authors:  R Raucci; F Rusolo; A Sharma; G Colonna; G Castello; S Costantini
Journal:  Cytokine       Date:  2012-09-27       Impact factor: 3.861

3.  Associations between adiponectin and two different cancers: breast and colon.

Authors:  Mehmet Ali Gulcelik; Kadri Colakoglu; Halil Dincer; Lutfi Dogan; Erdinc Yenidogan; Nese Ersoz Gulcelik
Journal:  Asian Pac J Cancer Prev       Date:  2012

Review 4.  Role of VHL gene mutation in human renal cell carcinoma.

Authors:  Wani Arjumand; Sarwat Sultana
Journal:  Tumour Biol       Date:  2011-11-29

Review 5.  The Heidelberg classification of renal cell tumours.

Authors:  G Kovacs; M Akhtar; B J Beckwith; P Bugert; C S Cooper; B Delahunt; J N Eble; S Fleming; B Ljungberg; L J Medeiros; H Moch; V E Reuter; E Ritz; G Roos; D Schmidt; J R Srigley; S Störkel; E van den Berg; B Zbar
Journal:  J Pathol       Date:  1997-10       Impact factor: 7.996

6.  Pathway signature and cellular differentiation in clear cell renal cell carcinoma.

Authors:  Han W Tun; Laura A Marlow; Christina A von Roemeling; Simon J Cooper; Pamela Kreinest; Kevin Wu; Bruce A Luxon; Mala Sinha; Panos Z Anastasiadis; John A Copland
Journal:  PLoS One       Date:  2010-05-18       Impact factor: 3.240

7.  Inverse association of leptin levels with renal cell carcinoma: results from a case-control study.

Authors:  Themistoklis N Spyridopoulos; Eleni Th Petridou; Nick Dessypris; Agapios Terzidis; Alkistis Skalkidou; Charalambos Deliveliotis; George P Chrousos
Journal:  Hormones (Athens)       Date:  2009 Jan-Mar       Impact factor: 2.885

8.  Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK/ERK1/2 and PI3K/Akt signaling pathways.

Authors:  Chiachen Chen; Yuan-Ching Chang; Michael S Lan; Mary Breslin
Journal:  Int J Oncol       Date:  2013-01-23       Impact factor: 5.650

9.  Body size and renal cell cancer incidence in a large US cohort study.

Authors:  Kenneth F Adams; Michael F Leitzmann; Demetrius Albanes; Victor Kipnis; Steven C Moore; Arthur Schatzkin; Wong-Ho Chow
Journal:  Am J Epidemiol       Date:  2008-06-09       Impact factor: 4.897

10.  Serum levels of resistin, adiponectin, and apelin in gastroesophageal cancer patients.

Authors:  Dorota Diakowska; Krystyna Markocka-Mączka; Piotr Szelachowski; Krzysztof Grabowski
Journal:  Dis Markers       Date:  2014-06-24       Impact factor: 3.434

View more
  11 in total

Review 1.  Nicotinamide is an inhibitor of SIRT1 in vitro, but can be a stimulator in cells.

Authors:  Eun Seong Hwang; Seon Beom Song
Journal:  Cell Mol Life Sci       Date:  2017-04-17       Impact factor: 9.261

Review 2.  Updated Functional Roles of NAMPT in Carcinogenesis and Therapeutic Niches.

Authors:  Tsung-Chieh Lin
Journal:  Cancers (Basel)       Date:  2022-04-19       Impact factor: 6.575

3.  Increased visceral adipose tissue in clear cell renal cell carcinoma with and without peritumoral collateral vessels.

Authors:  Federico Greco; Luigi Giuseppe Quarta; Rosario Francesco Grasso; Bruno Beomonte Zobel; Carlo Augusto Mallio
Journal:  Br J Radiol       Date:  2020-06-16       Impact factor: 3.039

Review 4.  The Role of Apelin in Cardiovascular Diseases, Obesity and Cancer.

Authors:  Marta B Wysocka; Katarzyna Pietraszek-Gremplewicz; Dorota Nowak
Journal:  Front Physiol       Date:  2018-05-23       Impact factor: 4.566

Review 5.  Study Progression of Apelin/APJ Signaling and Apela in Different Types of Cancer.

Authors:  Longfei Liu; Xiaoping Yi; Can Lu; Yong Wang; Qiao Xiao; Liang Zhang; Yingxian Pang; Xiao Guan
Journal:  Front Oncol       Date:  2021-04-12       Impact factor: 6.244

6.  Adipogenic Transdifferentiation and Regulatory Factors Promote the Progression and the Immunotherapy Response of Renal Cell Carcinoma: Insights From Integrative Analysis.

Authors:  Shuai Wang; Xiyi Wei; Chengjian Ji; Yichun Wang; Xi Zhang; Rong Cong; Ninghong Song
Journal:  Front Oncol       Date:  2022-03-09       Impact factor: 6.244

7.  Association between rs1862513 and rs3745367 Genetic Polymorphisms of Resistin and Risk of Cancer: A Meta-Analysis

Authors:  Mohammad Hashemi; Gholamreza Bahari; Farhad Tabasi; Abdolkarim Moazeni-Roodi; Saeid Ghavami
Journal:  Asian Pac J Cancer Prev       Date:  2018-10-26

8.  Impacts of RETN genetic polymorphism on breast cancer development.

Authors:  Chao-Qun Wang; Chih-Hsin Tang; Huey-En Tzeng; Lulu Jin; Jin Zhao; Le Kang; Yan Wang; Gui-Nv Hu; Bi-Fei Huang; Xiaoni Li; Yong-Ming Zhao; Chen-Ming Su; Hong-Chuan Jin
Journal:  J Cancer       Date:  2020-02-20       Impact factor: 4.207

Review 9.  Melanoma Progression under Obesity: Focus on Adipokines.

Authors:  Joanna Olszańska; Katarzyna Pietraszek-Gremplewicz; Dorota Nowak
Journal:  Cancers (Basel)       Date:  2021-05-10       Impact factor: 6.639

Review 10.  Renal Cell Cancer and Obesity.

Authors:  Anna Gluba-Brzózka; Jacek Rysz; Janusz Ławiński; Beata Franczyk
Journal:  Int J Mol Sci       Date:  2022-03-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.